Works by Zhenchang Sun

Results: 45
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

    Published in:
    Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1089, doi. 10.20892/j.issn.2095-3941.2021.0026
    By:
    • Jingjing Wu;
    • Fenghua Gao;
    • Wenhua Wang;
    • Xudong Zhang;
    • Meng Dong;
    • Lei Zhang;
    • Xin Li;
    • Ling Li;
    • Zhenchang Sun;
    • Xinhua Wang;
    • Xiaorui Fu;
    • Linan Zhu;
    • Mengjie Ding;
    • Songtao Niu;
    • Zhaoming Li;
    • Yu Chang;
    • Feifei Nan;
    • Jiaqian Yan;
    • Hui Yu;
    • Xiaolong Wu
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-018-0559-7
    By:
    • Li, Xin;
    • Cheng, Yasong;
    • Zhang, Mingzhi;
    • Yan, Jiaqin;
    • Li, Ling;
    • Fu, Xiaorui;
    • Zhang, Xudong;
    • Chang, Yu;
    • Sun, Zhenchang;
    • Yu, Hui;
    • Zhang, Lei;
    • Wang, Xinhua;
    • Wu, Jingjing;
    • Li, Zhaoming;
    • Nan, Feifei;
    • Tian, Li;
    • Li, Wencai;
    • Young, Ken H.
    Publication type:
    Article
    20
    21

    Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 11, p. 1889, doi. 10.1007/s00277-014-2136-7
    By:
    • Zhou, Zhiyuan;
    • Li, Xiang;
    • Chen, Changying;
    • Li, Xin;
    • Zhang, Lei;
    • Li, Ling;
    • Wang, Xinhua;
    • Ma, Wang;
    • Fu, Xiaorui;
    • Wu, Jingjing;
    • Sun, Zhenchang;
    • Zhang, Xudong;
    • Li, Zhaoming;
    • Yan, Jiaqin;
    • Chang, Yu;
    • Lu, Lisha;
    • Qin, Beibei;
    • Li, Xiaoli;
    • Wen, Jianguo;
    • Zhang, Mingzhi
    Publication type:
    Article
    22

    Complete Blood Count Score Model Integrating Reduced Lymphocyte‐Monocyte Ratio, Elevated Neutrophil‐Lymphocyte Ratio, and Elevated Platelet‐Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T‐Lymphoblastic Lymphoma.

    Published in:
    Oncologist, 2019, v. 24, n. 11, p. e1123, doi. 10.1634/theoncologist.2018-0789
    By:
    • Feng, Xiaoyan;
    • Li, Ling;
    • Wu, Jingjing;
    • Zhang, Lei;
    • Sun, Zhenchang;
    • Li, Xin;
    • Wang, Xinhua;
    • Yu, Hui;
    • Chang, Yu;
    • Wu, Xiaolong;
    • Zhou, Zhiyuan;
    • Wang, Guannan;
    • Li, Wencai;
    • Li, Zhaoming;
    • Zhang, Xudong;
    • Zhang, Mingzhi
    Publication type:
    Article
    23
    24

    Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study.

    Published in:
    International Journal of Cancer, 2021, v. 148, n. 6, p. 1470, doi. 10.1002/ijc.33329
    By:
    • Zhang, Lei;
    • Wang, Yan;
    • Li, Xin;
    • Li, Ling;
    • Wang, Xinhua;
    • Sun, Zhenchang;
    • Wu, Jingjing;
    • Fu, Xiaorui;
    • Zhang, Xudong;
    • Yu, Hui;
    • Wang, Guannan;
    • Chang, Yu;
    • Yan, Jiaqin;
    • Zhou, Zhiyuan;
    • Wu, Xiaolong;
    • Nan, Feifei;
    • Li, Wencai;
    • Zhang, Mingzhi
    Publication type:
    Article
    25
    26

    Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study.

    Published in:
    Cancer Management & Research, 2019, v. 11, p. 1363, doi. 10.2147/CMAR.S192143
    By:
    • Ma, Qianwen;
    • Chang, Yu;
    • Li, Ling;
    • Li, Xin;
    • Wang, Xinhua;
    • Wu, Jingjing;
    • Fu, Xiaorui;
    • Sun, Zhenchang;
    • Yu, Hui;
    • Zhang, Xudong;
    • Zhou, Zhiyuan;
    • Nan, Feifei;
    • Li, Zhaoming;
    • Liu, Xiyang;
    • Zhao, Qian;
    • Li, Yang;
    • Zhang, Lan;
    • Zhang, Mingzhi;
    • Zhang, Lei
    Publication type:
    Article
    27
    28
    29
    30
    31

    Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12032-9
    By:
    • Li, Zhaoming;
    • Zhang, Xudong;
    • Xue, Weili;
    • Zhang, Yanjie;
    • Li, Chaoping;
    • Song, Yue;
    • Mei, Mei;
    • Lu, Lisha;
    • Wang, Yingjun;
    • Zhou, Zhiyuan;
    • Jin, Mengyuan;
    • Bian, Yangyang;
    • Zhang, Lei;
    • Wang, Xinhua;
    • Li, Ling;
    • Li, Xin;
    • Fu, Xiaorui;
    • Sun, Zhenchang;
    • Wu, Jingjing;
    • Nan, Feifei
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.687374
    By:
    • Hu, Junxia;
    • Wang, Xin;
    • Chen, Fei;
    • Ding, Mengjie;
    • Dong, Meng;
    • Yang, Wanqiu;
    • Yin, Meifeng;
    • Wu, Jingjing;
    • Zhang, Lei;
    • Fu, Xiaorui;
    • Sun, Zhenchang;
    • Li, Ling;
    • Wang, Xinhua;
    • Li, Xin;
    • Guo, Shuangshuang;
    • Zhang, Dianbao;
    • Lu, Xiaohui;
    • Leng, Qing;
    • Zhang, Mingzhi;
    • Zhu, Linan
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45